US SB1008 | 2017-2018 | 115th Congress
Status
Spectrum: Slight Partisan Bill (Republican 8-5)
Status: Introduced on May 2 2017 - 25% progression, died in committee
Action: 2017-05-02 - Read twice and referred to the Committee on the Judiciary.
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 2 2017 - 25% progression, died in committee
Action: 2017-05-02 - Read twice and referred to the Committee on the Judiciary.
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Therapeutic Hemp Medical Access Act of 2017 This bill amends the Controlled Substances Act (CSA): to add definitions for the terms "cannabidiol," "cannabidiol-rich plants," and "tetrahydrocannabinol concentration"; to exclude cannabidiol and cannabidiol-rich plants from the definition of marijuana; and to remove cannabidiol and cannabidiol-rich plants from coverage under the CSA. It also specifies that no provision of this bill prohibits or restricts the use, production, or distribution of marijuana in a state in which such activities are legal under state law.
Title
Therapeutic Hemp Medical Access Act of 2017
Sponsors
Sen. Cory Gardner [R-CO] | Sen. Jeff Merkley [D-OR] | Sen. Lamar Alexander [R-TN] | Sen. Orrin Hatch [R-UT] |
Sen. Johnny Isakson [R-GA] | Sen. Mike Lee [R-UT] | Sen. Ron Johnson [R-WI] | Sen. Tammy Baldwin [D-WI] |
Sen. Mark Warner [D-VA] | Sen. Roy Blunt [R-MO] | Sen. Lindsey Graham [R-SC] | Sen. Ron Wyden [D-OR] |
Sen. Amy Klobuchar [D-MN] |
History
Date | Chamber | Action |
---|---|---|
2017-05-02 | Senate | Read twice and referred to the Committee on the Judiciary. |
Same As/Similar To
HB2273 (Related) 2017-06-02 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/115th-congress/senate-bill/1008/all-info |
Text | https://www.congress.gov/115/bills/s1008/BILLS-115s1008is.pdf |